We found that depletion of HJURP led to decreased tumor size and was more sensitive to doxorubicin (Fig. 7C, D), suggesting that HJURP activation is important for TNBC tumor growth and chemotherapy response in vivo. The gene discussed is HJURP; the disease is neoplasm.